Relationship between gut microbiota and immunity: reducing complications in critically ill patient

Autores

https://doi.org/10.37885/251120596

Palavras-chave:

Bacteria, therapy, modulation, intestine, illness, severity

Resumo

This analysis addresses the interaction between gut microbiota and immunity in critically ill patients, emphasizing the importance of maintaining a healthy microbiome in these cases. It’s crucial to understand the functions of the microbiota and its relationship with immunity, identify key studies on the topic, and point out strategies to reduce complications in ICU patients. It’s observed that an imbalance in the gut microbiota, characterized by a decrease in bacterial diversity, promotes colonization by pathogenic bacteria. This state of dysbiosis can lead to bacterial translocation, where microorganisms and toxins cross the intestinal barrier, causing systemic inflammation. Furthermore, dysbiosis affects neurotransmitter production, impairing the immune response and worsening the clinical condition of patients. Modulating the gut microbiota through the use of probiotics, prebiotics, and other interventions can be a promising strategy to improve immunity and reduce complications in critically ill patients. These approaches have shown potential in restoring microbial diversity and promoting a more balanced immune state. However, more research is needed to deepen the understanding of this relationship and develop effective therapeutic interventions that can be implemented in clinical practice. Thus, understanding the gut microbiota can significantly contribute to improving the care of critically ill patients.

Downloads

Os dados de download ainda não estão disponíveis.

PlumX

Referências

ADAK, Atanu; KHAN, Mojibur R. An insight into gut microbiota and its functionalities. Cellular and Molecular Life Sciences, v. 76, p. 473-493, 2019.

BALMER, Maria L. et al. Microbiota-derived compounds drive steady-state granulopoiesis via MyD88/TICAM signaling. The Journal of Immunology, v. 193, n. 10, p. 5273-5283, 2014.

BELKAID, Yasmine; HAND, Timothy W. Role of the microbiota in immunity and inflammation. Cell, v. 157, n. 1, p. 121-141, 2014.

BELKAID, Yasmine; HARRISON, Oliver J. Homeostatic immunity and the microbiota. Immunity, v. 46, n. 4, p. 562-576, 2017.

CHAMBERS, Edward S. et al. Role of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health. Current Nutrition Reports, v. 7, p. 198-206, 2018.

CHULUCK, Jonas Bruno Giménez et al. A influência da microbiota intestinal na saúde humana: uma revisão de literatura. Brazilian Journal of Health Review, v. 6, n. 4, p. 16308-16322, 2023.

CORRÊA‐OLIVEIRA, Renan et al. Regulation of immune cell function by short‐chain fatty acids. Clinical & translational immunology, v. 5, n. 4, p. e73, 2016.

DE VOS, Willem M. et al. Gut microbiome and health: mechanistic insights. Gut, v. 71, n. 5, p. 1020-1032, 2022.

DE VOS, Willem M.; DE VOS, Elisabeth AJ. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutrition Reviews, v. 70, n. suppl_1, p. S45-S56, 2012.

DEMARTINI, Breno Leite. Protocolos nutricionais para preservar as junções compactas do trato gastrointestinal e diminuir marcadores inflamatórios no sangue de bovinos confinados. 2022.

DEN BESTEN, Gijs et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research, v. 54, n. 9, p. 2325-2340, 2013.

EARLEY, Zachary M. et al. Burn injury alters the intestinal microbiome and increases gut permeability and bacterial translocation. PloS One, v. 10, n. 7, p. e0129996, 2015.

FURNESS, John B. The enteric nervous system and neurogastroenterology. Nature Reviews Gastroenterology & hepatology, v. 9, n. 5, p. 286-294, 2012.

GOMAA, Eman Zakaria. Human gut microbiota/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek, v. 113, n. 12, p. 2019-2040, 2020.

HOOPER, Lora V.; LITTMAN, Dan R.; MACPHERSON, Andrew J. Interactions between the microbiota and the immune system. Science, v. 336, n. 6086, p. 1268-1273, 2012.

HOOPER, Lora V.; MACPHERSON, Andrew J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nature Reviews Immunology, v. 10, n. 3, p. 159-169, 2010.

KIEPER, William C. et al. Cutting edge: recent immune status determines the source of antigens that drive homeostatic T cell expansion. The Journal of Immunology, v. 174, n. 6, p. 3158-3163, 2005.

KLINGENSMITH, Nathan J.; COOPERSMITH, Craig M. The gut as the motor of multiple organ dysfunction in critical illness. Critical Care Clinics, v. 32, n. 2, p. 203-212, 2016.

LANKELMA, Jacqueline M. et al. Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study. Intensive care medicine, v. 43, p. 59-68, 2017.

LEVY, Maayan et al. Dysbiosis and the immune system. Nature Reviews Immunology, v. 17, n. 4, p. 219-232, 2017.

LUYER, Misha D. et al. Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infection and Immunity, v. 73, n. 6, p. 3686-3692, 2005.

MANZANARES, William et al. Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Critical Care, v. 20, p. 1-19, 2016.

MANZANARES, William et al. Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Critical Care, v. 20, p. 1-19, 2016.

MEIJER, Kees; DE VOS, Paul; PRIEBE, Marion G. Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? Current Opinion in Clinical Nutrition & Metabolic Care, v. 13, n. 6, p. 715-721, 2010.

O’KEEFE, Stephen JD et al. Effect of fiber supplementation on the microbiota in critically ill patients. World Journal of Gastrointestinal Pathophysiology, v. 2, n. 6, p. 138, 2011.

O’MAHONY, Siobhain M. et al. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research, v. 277, p. 32-48, 2015.

OLIVEIRA, A.; HASE, K. Parceiros na Síndrome do Intestino Permeável: Disbiose Intestinal e Autoimunidade. Frontiers in Immunology, v. 12, 2021.

PAMER, E. G. Ressuscitando a microbiota intestinal para combater patógenos resistentes a antibióticos. Science, v. 352, p. 535-538, 2016.

RAJILIĆ-STOJANOVIĆ, Mirjana; DE VOS, Willem M. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiology Reviews, v. 38, n. 5, p. 996-1047, 2014.

RASTELLI, Marialetizia; CANI, Patrice D.; KNAUF, Claude. The gut microbiome influences host endocrine functions. Endocrine Reviews, v. 40, n. 5, p. 1271-1284, 2019.

SAMUELSON, Derrick R.; WELSH, David A.; SHELLITO, Judd E. Regulation of lung immunity and host defense by the intestinal microbiota. Frontiers in Microbiology, v. 6, p. 1085, 2015.

SILVEIRA, Carlos Augusto Carvalho et al. Transplante de microbiota fecal no tratamento da infecção por Clostridium difficile: estado da arte e revisão de literatura. Journal Archives of Health, v. 5, n. 3, p. e1840-e1840, 2024. Disponível em: https://ojs.latinamericanpublicacoes.com.br/ojs/index.php/ah/article/view/1840. Acesso: 7 de out. 2024.

SOMMER, Felix; BÄCKHED, Fredrik. The gut microbiota—masters of host development and physiology. Nature Reviews Microbiology, v. 11, n. 4, p. 227-238, 2013.

TREMAROLI, Valentina; BÄCKHED, Fredrik. Functional interactions between the gut microbiota and host metabolism. Nature, v. 489, n. 7415, p. 242-249, 2012.

VIVARELLI, Marco; MONTALTI, Roberto; RISALITI, Andrea. Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update. World Journal of Gastroenterology: WJG, v. 19, n. 42, p. 7316, 2013.

WATSON, R. Scott et al. The epidemiology of severe sepsis in children in the United States. American Journal of Respiratory and Critical Care Medicine, v. 167, n. 5, p. 695-701, 2003.

WISCHMEYER, Paul E.; MCDONALD, Daniel; KNIGHT, Rob. Role of the microbiome, probiotics, and ‘dysbiosis therapy’in critical illness. Current Opinion in Critical Care, v. 22, n. 4, p. 347-353, 2016.

Arquivos adicionais

Publicado

24/06/2026

Como Citar

Relationship between gut microbiota and immunity: reducing complications in critically ill patient. (2026). Revista Brasileira De Ciência Aberta, 3, 1-17. https://doi.org/10.37885/251120596